Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Glycoconjugate vaccines. What next?

K E Stein

    International Journal of Technology Assessment in Health Care
    |January 1, 1994
    PubMed
    Summary

    Haemophilus influenzae type b conjugate vaccines protect infants from invasive diseases. Further research into glycoconjugates is needed for optimal vaccine development, aligning with the Children's Vaccine Initiative.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Immunogenicity: concepts/issues/concerns.

    Developments in biologicals·2002
    Same author

    The regulation of biologic products derived from bioengineered plants.

    Current opinion in biotechnology·2001
    Same author

    Use of a quantitative product-enhanced reverse transcriptase assay to monitor retrovirus levels in mAb cell-culture and downstream processing.

    Biotechnology progress·2001
    Same author

    The ability of B cells and dendritic cells to present antigen increases during ontogeny.

    Journal of immunology (Baltimore, Md. : 1950)·2000
    Same author

    A novel activation induced lymphocyte surface antigen, 90.12, is also expressed on apoptotic cells.

    Scandinavian journal of immunology·2000
    Same author

    Murine immune response to Neisseria meningitidis group C capsular polysaccharide: analysis of monoclonal antibodies generated in response to a thymus-independent antigen and a thymus-dependent toxoid conjugate vaccine.

    Infection and immunity·1999

    Area of Science:

    • Immunology
    • Vaccinology
    • Microbiology

    Background:

    • Invasive diseases caused by encapsulated organisms pose a significant threat to infants.
    • The success of Haemophilus influenzae type b conjugate vaccines demonstrates the principle of protecting infants through vaccination.

    Purpose of the Study:

    • To outline the chemical and immunological specifications required for optimal glycoconjugate vaccines.
    • To support the goals of the Children's Vaccine Initiative through vaccine development.

    Main Methods:

    • Review of existing data on conjugate vaccines.
    • Analysis of chemical and immunological properties of glycoconjugates.

    Main Results:

    • Established the protective principle of conjugate vaccines against encapsulated organisms.
    • Highlighted the need for defined specifications for glycoconjugate vaccine development.

    Conclusions:

    • Infant protection against invasive encapsulated bacterial diseases is achievable with conjugate vaccines.
    • Clear chemical and immunological specifications are crucial for advancing glycoconjugate vaccine technology for initiatives like the Children's Vaccine Initiative.

    Related Experiment Videos